Literature DB >> 17439828

Cutaneous T-cell and NK-cell lymphomas: the WHO-EORTC classification and the increasing recognition of specialized tumor types.

Marsha C Kinney1, Dan Jones.   

Abstract

Cases drawn from Session 5 of the 2005 Society for Hematopathology/European Association for Haematopathology Workshop on progress in T-cell and natural killer (NK)-cell malignancies are used as a framework to review the current classification of T-cell and NK-cell malignancies in skin. In comparison with the typical pattern and course of mycosis fungoides (MF), selected variants of MF that can be difficult to diagnose are discussed. Cutaneous CD30+ lymphoproliferative disorders are also presented in detail. Particular focus is placed on the recognition of rare but clinically more aggressive cytotoxic lymphomas in the skin. Overall, diagnostic pitfalls and new information regarding disease pathogenesis brought up by the Workshop cases are provided. In addition, a general approach to the diagnosis of cutaneous T-cell lymphomas is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17439828     DOI: 10.1309/MTTM86UT1XFQL7RV

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

Review 1.  Peripheral T and NK cell non-hodgkin lymphoma a challenge for diagnosis.

Authors:  Daniela Vasile; Ana-Maria Vladareanu; Horia Bumbea
Journal:  Maedica (Buchar)       Date:  2014-03

Review 2.  Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy.

Authors:  Thomas R Webb; Jake Slavish; Rani E George; A Thomas Look; Liquan Xue; Qin Jiang; Xiaoli Cui; Walter B Rentrop; Stephan W Morris
Journal:  Expert Rev Anticancer Ther       Date:  2009-03       Impact factor: 4.512

3.  Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases.

Authors:  Porcia T Bradford; Susan S Devesa; William F Anderson; Jorge R Toro
Journal:  Blood       Date:  2009-03-11       Impact factor: 22.113

Review 4.  Human natural killer cells.

Authors:  Michael A Caligiuri
Journal:  Blood       Date:  2008-08-01       Impact factor: 22.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.